slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 28,771-28,800
Pages 1,349
Rows per page 30
Beat
28,771-28,800 of 40,452
16
Includes a specific callout for 'Unfair access to pool of excellent French engineers' with a grid of team member photos.Front | Start Up Pitch Deck | 21 slides · Front
Pitch deck Investor relations Beat · Team1 hit
20
Front | Start Up Pitch Deck | 21 slidesFront | Start Up Pitch Deck | 21 slides · Front
Pitch deck Investor relations Beat · Market SizeLoop · Why Now1 hit
19
The chart is a classic waterfall bridge showing the impact of platform mix, price, and efficiency on gross margin.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
20
The slide uses a waterfall chart to bridge the gap between 2015 and 2016 EBITDA margins.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
21
Includes a footnote regarding an undrawn $100 million revolving credit facility.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Visualization1 hit
22
Inovalon | Results Presentation Deck | 22 slidesInovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Visualization1 hit
13
Includes sensitivity table for WACC vs. Terminal EBITDA Multiple.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
14
LionTree | Investment Banking Pitch Book | 25 slidesLionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
15
Includes valuation bridge, EBITDA multiples, leverage ratios, and a multi-line stock performance chart.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
16
Projections per Luna management, as reviewed by Saturn.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
17
Assumes mid-year convention, discounted back to 3/31/16; based on balance sheet as of 3/31/16 (net debt of $788mm), equity in affiliates of $808mm and minority interest of $98mm; excludes value of operating losses which have been incorporated in the 15.0% tax rate.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
18
LionTree | Investment Banking Pitch Book | 25 slidesLionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
19
Includes CAGR calculations and synergy adjustments.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
20
Includes a DCF table for 2017E-2020E and two sensitivity tables for value per share and total synergy value.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
21
Microsoft | Mergers and Acquisitions Presentation Deck | 24 slidesMicrosoft | Mergers and Acquisitions Presentation Deck | 24 slides · Microsoft
Conference presentation Investment bank Beat · Why Now1 hit
22
Microsoft | Mergers and Acquisitions Presentation Deck | 24 slidesMicrosoft | Mergers and Acquisitions Presentation Deck | 24 slides · Microsoft
Conference presentation Investment bank Beat · Why Now1 hit
23
Slide 23 of a presentation, likely related to Microsoft's acquisition of LinkedIn.Microsoft | Mergers and Acquisitions Presentation Deck | 24 slides · Microsoft
Conference presentation Investment bank Beat · Why Now1 hit
11
The slide showcases hardware components for clinical chemistry, immunochemistry, hematology/immunology, and molecular biology.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
12
The slide displays six distinct hardware components: Camera, Material Handling Robot, Cartridge, Sonicator, Thermocycler, and Centrifuge.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
13
The slide includes a disclaimer about FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
14
The slide includes a disclaimer about FDA approval status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
15
Includes a disclaimer regarding FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
16
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
17
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
18
The slide includes a standard FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
19
The slide includes a disclaimer about FDA status at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
20
Includes a regulatory disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
21
The slide displays a central cartridge/tray surrounded by individual components with labels and volume specifications.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
22
The slide includes a disclaimer at the bottom regarding FDA approval status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
23
The slide is essentially a product reveal combined with a legal disclaimer.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit